About
Editors and people

Editors for Immunology and Inflammation

We aim to review studies that provide new insights into the development and function of the immune system and inflammatory processes, irrespective of model organism. We also welcome studies on associated human diseases, new therapeutic strategies, and development of new methodologies or interdisciplinary studies that integrate immunology and inflammation with other research fields. Read the latest research in this subject area.

Type

All sections

Senior editors

Arturo Casadevall

Johns Hopkins Bloomberg School of Public Health, United States

Arturo Casadevall, MD, PhD is a Bloomberg Distinguished Professor and Chair of the W Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He obtained his BA in Chemistry at Queens College of the City University of New York. Previously, he served as Director of the Division of Infectious Diseases at Montefiore Medical Center, the University Hospital and Academic Medical Center for Einstein, from 2000–2006 and as Chair of the Department of Microbiology and Immunology from 2006–2014.

Dr Casadevall received both his MD and PhD (biochemistry) degrees from New York University. Subsequently, he completed his internship and residency in internal medicine at Bellevue Hospital in New York. He then completed subspecialty training in infectious diseases at Montefiore and Einstein. The author of over 700 scientific papers, numerous books and book chapters, Dr Casadevall’s major research interests are in fungal pathogenesis and the mechanisms of antibody action. In the area of biodefense, he has an active research program to understand the mechanisms of antibody–mediated neutralization of Bacillus anthracis toxins.

In recent years, Dr Casadevall has become interested in problems with the scientific enterprise and with his collaborators shown that misconduct accounts for the majority of retracted publications. He has suggested a variety of reforms to the way science is done. Dr Casadevall is the editor–in–chief of mBio, the first open access general journal of the American Society of Microbiology, and is on the editorial board of several journals including the Journal of Infectious Diseases and the Cell Surface.

He has also served in numerous NIH committees including those that drafted the NIAID Strategic Plan and the Blue Ribbon Panel on Biodefense Research. He served on the National Academy of Sciences panel that reviewed the science on the FBI investigation of the anthrax terror attacks of 2001 and has served on the NAS Committee of Federal Regulations and Reporting requirements. He has also served as a member of the National Science Advisory Board for Biosecurity from 2005–2014. In 2008, he was recognized by the American Society of Microbiology with the William Hinton Award for mentoring scientists from underrepresented groups. In 2015, Dr Casadevall was appointed a Commissioner to the National Commission on Forensic Science, the United States Department of Justice. He has served as President of the Medical Mycology Society of America, Chair of American Society for Microbiology Division F, Chair of the American Society for Microbiology Career Development Committee, Co–Chair of the National Institute of Allergy and Infectious Diseases Board of Scientific Counselors, and currently serves on the Scientific Council/Advisory Board for the Pasteur Institut and VIB Research Institute in Belgium. He is a member of the American Society for Clinical Investigation, American College of Physicians and the Association of American Physicians, and was elected Fellow of the American Association for the Advancement of Science and the American Academy of Microbiology. In 2014, he became an elected member of the National Academy of Medicine and in 2017, he was elected to the American Academy of Arts and Sciences.

Expertise
Immunology and Inflammation
Medicine
Microbiology and Infectious Disease

Research focus
molecular microbiology and immunology
pathogenic microbes
cryptococcosis
anthrax
mycobacterium tuberculosis
vaccines

Experimental organism
Cryptococcus neoformans
Bacillus anthracis

Competing interests statement
Arturo Casadevall is Editor in Chief of mBio (until 2025), and serves on the editorial boards of Journal of Experimental Medicine, Journal of Clinical Investigation, and Journal of Infectious Diseases.
Miles P Davenport

University of New South Wales, Australia

Miles Davenport is Professor of Medicine and Head of the Infection Analytics Program at the Kirby Institute for Infection and Immunity at UNSW Sydney. He graduated in medicine from the University of Sydney and completed his DPhil at the University of Oxford in immunology before retraining in mathematical biology. He leads a team of applied mathematicians who use statistical analysis and modelling to understand host-pathogen interactions in infection and immunity. This involves collaboration with a wide variety of experimental and clinical scientists both in Australian and internationally. Major areas of investigation include understanding HIV latency, malaria immunity and treatment, and neonatal immune development. He is a past-President of the Australasian Society for Immunology and is supported by an NHMRC (Australia) Investigator grant.

Expertise
Immunology and Inflammation
Microbiology and Infectious Disease
Epidemiology and Global Health
Medicine

Research focus
virology
immunity
vaccines
HIV/AIDS
mathematical modelling
host-pathogen interactions
biostatistics

Competing interests statement
Miles Davenport receives funding from the National Health and Medical Research Council (Australia), the Australian Research Council, and the National Institutes of Health (USA). He is an Associate Editor at PLoS Computational Biology and on the Editorial Board of Immunology and Cell Biology.
Betty Diamond

The Feinstein Institute for Medical Research, United States

Betty Diamond received an MD from Harvard Medical School. She performed a residency in Internal Medicine at Columbia Presbyterian Medical Center, and then a post-doctoral fellowship in Immunology with Dr Matthew Scharff at the Albert Einstein College of Medicine. She is currently Director of the Institute of Molecular Medicine at the Feinstein Institute for Medical Research.

Dr Diamond’s research has focused on the induction and pathogenicity of anti-DNA antibodies in Systemic Lupus Erythematosus. She showed that somatic mutation of immunoglobulin genes can generate autoantibodies in mice and humans, making the germinal center a focus in disease pathogenesis. Her laboratory has also demonstrated that a subset of anti-DNA antibodies cross-reacts with the NMDA receptor and showed that autoantibodies can cause aspects of neuropsychiatric lupus, creating a paradigm for antibody-mediated changes in brain function in many conditions. Most recently, she has developed a research program on the immunomodulatory functions of C1q.

She received the Outstanding Investigator Award of the ACR in 2001, the Lee Howley Award from the Arthritis Foundation in 2002, and the Recognition Award from the National Association of MD-PhD Programs in 2004 and the AAI Distinguished Fellow Award in 2019. In 2006, she was elected to the Institute of Medicine and became a fellow of the AAAS. She has served on the Scientific Council of NIAMS and the Board of Directors of the American College of Rheumatology. She is a past President of the American Association of Immunologists.

Expertise
Medicine
Immunology and Inflammation

Research focus
B cells
systemic lupus
neuropsychiatric lupus
autoantibodies
autoimmunity

Experimental organism
human
mouse

Competing interests statement
Betty Diamond receives funding from the NIH, LuCIN (Lupus Clinical Investigators Network), Lupus Research Alliance, DOD Lupus and Leidos Biomedical Research, Inc.. She is the Chief Editor at Molecular Medicine and a Deputy Editor for Frontiers in Immunology.
Wendy S Garrett

Harvard T.H. Chan School of Public Health, United States

Wendy Garrett is a Professor of Immunology and Infectious Diseases at the Harvard T. H. Chan School of Public Health, co-Director of the Harvard Chan Center for the Microbiome in Public Health, and an Associate Member of the Broad Institute. Her work explores host-microbiota interactions underlying mucosal immune homeostasis, gastrointestinal inflammatory disorders, and cancer. She graduated from the Yale College; received her MD PhD from Yale University and completed post-graduate training at Harvard.

Expertise
Immunology and Inflammation
Microbiology and Infectious Disease
Medicine

Research focus
host-microbiota interactions
microbiome
mucosal immunology

Competing interests statement
Wendy Garrett serves on advisory boards of Evelo Biosciences, Kintai Therapeutics, and Leap Therapeutics. She is a member of the Cell Reports and Journal of Clinical Microbiology editorial boards.
Diane M Harper

University of Michigan, United States

Diane M Harper, MD, MPH, MS, completed her undergraduate and graduate degrees at the Massachusetts Institute of Technology in Cambridge, Massachusetts, in the fields of Chemical Engineering and Polymerics. She received her medical and public health degrees from the University of Kansas in Kansas City, where she also did residencies in Gynecology/Obstetrics and Family Medicine. Dr Harper has spent the majority of her professional career at Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, as clinician, teacher and researcher in the Departments of Obstetrics and Gynecology, Community and Family Medicine and Women’s and Gender Studies, including improving life for LGBTQ.

She has received the Society of Teachers of Family Medicine (STFM) Excellence in Education Award and the Curtis Hames Research Award honoring her for changing medical care for women through evidence based research. She served as the Chair of Family and Geriatric Medicine at the University of Louisville during which time she also served on the United States Preventive Services Task Force.

She currently is a tenured Professor at the University of Michigan, serving as the Director for Research Management within the Michigan Institute of Clinical and Health Research, one of 50 Clinical and Translational Science Award Research Hubs across the United States. To date she has over 250 peer reviewed publications with over 27,000 citations, and over 40,000 downloads of her seminal review of HPV vaccines.

While at Dartmouth she developed and directed the Gynecologic Cancer Prevention Research Group based at the Norris Cotton Cancer Center in which research on all aspects of HPV associated diseases, specifically cervical cancer prevention was conducted. She is an internationally recognized expert on Human Papillomavirus, the cause of cervical cancer, and its prophylactic and therapeutic vaccines. She has published the seminal clinical research on HPV vaccines and lectured internationally in over 100 countries. She has served on NCI research committees, European research study sections, addressed the Council on Foreign Affairs, and served as a technical advisor to the World Health Organization. Dr Harper has been honored as one of the top clinicians in her field in the US, and Family Physician of the Year in New Hampshire in 2006.

Expertise
Medicine
Epidemiology and Global Health
Microbiology and Infectious Disease
Immunology and Inflammation

Research focus
HPV associated diseases
primary care
women's health
cancer precursor detection
health behaviours
epidemiology
cancer screening

Experimental organism
human

Competing interests statement
Diane Harper has received funding from NCI, NCATS, NHLBI, CDC, multiple national philanthropic organizations, including the American Cancer Society, The Robert Wood Johnson Foundation, and the Susan G Komen Foundation, in addition to state and local funding agencies and collaborations with industry. She serves in editorship capacities on boards including the Annals of Family Medicine, Preventive Medicine Reports, PLoS ONE, and Gynecologic Oncology. She is a peer reviewer for The Lancet, The New England Journal of Medicine, JAMA, among other journals.
Tony Ng

King's College London, United Kingdom

Tony Ng (FMEDSCI, MB ChB, MRCP, FRCPath, PhD) brings a rich spectrum of knowledge and capabilities with clinical experience in treating AIDS patients (with opportunistic infections and cancers) and fundamental immunology skills. He is also a pioneer of molecular imaging in cancer. He was the first person to use antibody based fluorescence lifetime imaging (FLIM) approaches in tumour cells and tissues to monitor protein states and function. He has published on how to visualize protein biochemistry in preclinical models; as well as in patient-derived cancer tissues for establishing in vitro/ companion diagnostics. He has adopted a multidisciplinary approach to understand cancer recurrence and also to stratify molecularly targeted agents in combination with immunotherapy. His research bridges the gap between physics, biology and medicine, particularly in the field of translational cancer research.

For clinical translation, he has the proven ability to coordinate and work cooperatively with colleagues and leaders in a wide variety of disciplines (imaging, cell biology, oncology, bioinformatics, surgery, pathology, genomics, as well as physical science disciplines such as mathematics, physics, chemistry and engineering). He has directed the KCL and UCL Comprehensive Cancer Imaging Centre (CCIC, one of four centres funded by CRUK & EPSRC in the UK) since its inception in 2008. The vision for the CCIC is to develop novel imaging (PET and MRI) technologies and use them in combination with clinicopathological assessment, genomics and in-house nanoscopic imaging to measure protein interactions in the context of interventional trials. In such trial context, the tissue imaging (FLIM histology) approach he has developed and refined over the years is beginning to reveal ErbB/ HER receptor rewiring as a mechanism of resistance in human tumours under selection pressure such as cetuximab.

Tony Ng is the current Director of the Comprehensive Cancer Centre, part of the KCL School of Cancer & Pharmaceutical Sciences, and the National Institute for Health and Care Research (NIHR) Guy’s & St Thomas’ Biomedical Research Centre (BRC) Cancer Theme. In 2022, he joined GSK on a part-time basis, to help establish the GSK-KCL Translational Oncology Research Hub which was which was announced in September 2021. The aim is to apply his clinical medicine training as well as immunology, biochemistry and imaging expertise to accelerate the development of the anti-cancer drugs. HIs experience of collaborating with mathematicians/theoretical physicists creates an opportunity to bridge the biology & AI/ML interface, an essential component of delivering the innovative Digital biological twin vision.

Training/expertise: Medicine, Immunology, Cancer cell biology, Biochemistry and Optical Imaging/Biophysics as well as preclinical Radionuclide imaging.

Expertise
Medicine
Cancer Biology
Immunology and Inflammation

Research focus
imaging
biomarkers
trial
immune
cancer
reverse translation
exosome
organoid
tumour microenvironment

Competing interests statement
At KCL, Tony Ng receives funding from Cancer Research UK, Medical Research Council, Wellcome Leap Inc., European Commission and GSK. He is employed on a part time basis as the Vice President of the Digital biological twin Unit at GSK.
Satyajit Rath

Indian Institute of Science Education and Research (IISER), Pune, India

Satyajit Rath was trained as a physician and a pathologist in Pune and Mumbai, India. He has worked on various issues related to the mechanisms involved in the development and functioning of the immune system since the nineteen-eighties, initially in post-doctoral stints across the world and then as a faculty member at the National Institute of Immunology (NII) in New Delhi over 1991-2017. Over 2017-2018, he held the Agharkar Chair at the Agharkar Research Institute, Pune, India. Currently, he is a visiting professor at the Indian Institute of Science Education and Research (IISER) in Pune, and an adjunct faculty member at the Translational Health Science and Technology Institute, Faridabad, India. Satyajit also works on science-and-society policies as well as science education and outreach with both government agencies and civil society groups.

Expertise
Immunology and Inflammation

Research focus
immune physiology
lymphocyte development
lymphocyte responses
macrophage activation
immunity in disease

Competing interests statement
Research support for Satyajit's group over the years has come mainly from agencies of the government of India. He serves as a member of the scientific advisory committees/councils as well as management boards of a number of life science institutions in India. He currently serves as an Associate Editor for Frontiers in Immunology. He is a non-executive director of Ahammune Biosciences Private Limited, Pune, India, and a member of the scientific advisory boards of Curadev Pharma Private Limited, NOIDA, India, and Mynvax Private Limited, Bangalore, India.
Carla V Rothlin

Yale University, United States

Carla V Rothlin, PhD is the Dorys McConnell Professor of Immunobiology and Pharmacology at Yale School of Medicine, HHMI Faculty Scholar and co-leader of the Cancer Immunology Program of the Yale Cancer Center. Dr Rothlin studied Biochemistry and Pharmacy at the University of Buenos Aires, where she also performed her graduate studies under the direction of Dr. Ana Belen Elgoyhen on nicotinic receptors expressed in the inner ear. Following her PhD, Dr Rothlin moved to San Diego, California and joined Dr Greg Lemke's lab at the Salk Institute for Biological Studies. Dr Rothlin was appointed as an Assistant Professor in Immunobiology at Yale School of Medicine in 2009. Dr Rothlin co-directs a research laboratory with Dr Sourav Ghosh (Associate Professor of Neurology and Pharmacology at Yale School of Medicine). Their laboratory focuses on mechanisms that underlie the regulation of inflammation and the homeostatic control of immune function. Their laboratory has identified the function of the TAM receptor tyrosine kinases in the negative regulation of the immune response and resolution of inflammation. Dr Rothlin’s contributions have been recognized by numerous foundations, such as the PEW Foundation and Howard Hughes Medical Institute. Dr Rothlin is also highly committed to Yale’s education mission and was appointed Director of Graduate Studies in Immunobiology in 2018.

Expertise
Immunology and Inflammation

Research focus
innate immunity
response to cell death
inflammation
macrophage biology
cancer immunology

Experimental organism
mouse

Competing interests statement
Carla Rothlin is funded by the NIH, HHMI, United States-Israel Binational Science Foundation, Kenneth Rainin Foundation, Roche Translational and Clinical Research Center, Inc. and the Ludwig Family Foundation. She is a member of the Minority Affairs Committee of The American Association of Immunologist. She holds an editorial board role at Immunology & Cell Biology and was previously a Reviewing Editor for eLife. She is on the advisory board of Roche (Immunology Incubator Board Member), Decode Consortium (External Advisory Board Member), Life Science Alliance (Member Advisor Editorial Board) and ImCORE (Member Oversight Committee). Dr Rothlin is also a Scientific Founder and SAB member of Surface Oncology.
Sara L Sawyer

University of Colorado Boulder, United States

Dr Sara Sawyer is a Professor at the University of Colorado Boulder. She has received national and international prizes in virology. In 2011, President Barack Obama awarded her the Presidential Early Career Award for Scientists and Engineers at the White House. In 2022, she received the Director’s Pioneer award from the National Institutes of Health. She is a member of the NIH Office of AIDS Research Advisory Council. In 2020, she co-founded Darwin Biosciences, an infectious disease diagnostics company located in Boulder, Colorado. She holds a PhD in Genetics from Cornell University. Her research focuses on animal viruses that infect humans.

Dr Sawyer is an expert in viral zoonosis, immunology, virology, evolution, genetic conflict, model organisms, viral reservoirs, infectious disease diagnostics, HIV, dengue, and influenza viruses.

Expertise
Microbiology and Infectious Disease
Evolutionary Biology
Immunology and Inflammation

Research focus
virology
viral host-switching and zoonosis
host-virus arms races
innate immunity
genomics
HIV
SARS-CoV-2
dengue viruses
arenaviruses
influenza viruses

Experimental organism
human
viruses
tissue culture

Competing interests statement
Sara Sawyer is a co-founder of Darwin Biosciences, which develops infectious disease diagnostics. She is a consultant for the US government on biomedical issues relevant to national defense. She receives funding from the National Institutes of Health, the Burroughs Wellcome Fund, and the Department of Defense.
Hiroshi Takayanagi

The University of Tokyo, Japan

Hiroshi Takayanagi, MD, PhD graduated from the Faculty of Medicine, University of Tokyo in 1990. Originally trained as an orthopaedic surgeon and rheumatologist in the Department of Orthopaedic Surgery, University of Tokyo, Dr Takayanagi began his basic research career in 1996. He was awarded his PhD in 2001 by the University of Tokyo and became Assistant Professor at the Department of Immunology where he studied the regulation of bone metabolism by the immune system by focusing on the control of osteoclast differentiation. In 2012, he was promoted to Professor, Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo. Dr Takayanagi received the 2019 Japan Academy Prize for his studies on osteoimmunology.

Expertise
Immunology and Inflammation
Medicine

Research focus
arthritis
osteoporosis
immune tolerance
osteoimmunology
autoimmunity
fibroblast
osteoclast
T cells

Competing interests statement
Hiroshi Takayanagi has received funding from the Ministry of Education, Culture, Sports, Science & Technology, the Japan Agency for Medical Research and Development, and Japan Society for the Promotion of Science.He is an Editorial Board Member of Annals of the Rheumatic Diseases and Bone Research, an Associate Editor of Inflammation and Regeneration and Journal of Bone and Mineral Metabolism, and a Transmitting Editor of Modern Rheumatology.
Tadatsugu Taniguchi

Research Center for Advanced Science and Technology, The University of Tokyo, Japan

Tada Taniguchi is Professor Emeritus of The University of Tokyo and Advisor to the Office of President, working at the Research Center for Advanced Science and Technology of the University. He also served as Director of the Max Planck–The University of Tokyo Center for Integrative Inflammology from 2014 to 2018. He received his Ph.D. from the University of Zurich. His work principally concerns the mechanisms of signal transduction and gene expression that underlie immunity and oncogenesis. Many of his research projects have stemmed from his original discovery of two cytokine genes, interferon-beta and interleukin-2. These discoveries have laid the groundwork for the molecular characterization of the various systems of cytokines as well as therapeutic advances achieved by the administration of cytokines. One extension of this research was his discovery of a new family of transcription factors, the interferon regulatory factors (IRFs), which he and others have since identified as playing integral roles in the regulation of the immunity, inflammation and cancer. He has received numerous awards, including the Robert Koch Prize, Pezcoller-AACR International Award for Cancer Research, and was bestowed the Person of Cultural Merit award from the Government of Japan. He was also elected Foreign Associate Member of the National Academy of Sciences, USA, in 2003, International Member of the National Academy of Medicine in 2016 and Associate Member of EMBO in 2018.

Expertise
Immunology and Inflammation

Research focus
inflammation
innate immunity
adaptive immunity
immunological disease
anti-tumor immunity
gene regulation in immune cells
signaling in immune cells
gene regulation in host defence

Competing interests statement
Tada Taniguchi has received funding from the Ministry of Education, Culture, Sports, Science & Technology, and Japan Agency for Medical Research and Development in Japan. He is a member of the editorial boards of Proceedings of the National Academy of Sciences, and Immunity. He is a member of the board of directors of the Japan Molecular Biology Society, and served as member of the Science Council of Japan between 2005 and 2011. He also served as co-chairperson of the International Affairs Committee of The American Association for Cancer Research between 2002 and 2008.
Aleksandra Walczak

Ecole Normale Superieure, France

Aleksandra Walczak received her PhD in physics at UCSD working on models of stochastic gene expression. After a graduate fellowship at KITP, she was a Princeton Center for Theoretical Science Fellow, focusing on applying information theory to signal processing in small gene regulatory networks. Currently she is a CNRS researcher at the Ecole Normale Superieure in Paris, interested in a variety of problems in the physics of living systems.

She actively works on development, collective behavior of bird flocks and statistical descriptions of the immune system.

Expertise
Computational and Systems Biology
Immunology and Inflammation
Physics of Living Systems

Research focus
biophysics
quantitative immunology
probabilistic data analysis
theoretical models
development
collective behaviour

Competing interests statement
Aleksandra Walczak is the recipient of a CNRS-Chicago Cooperation Grant, a FACCTS CNRS-Chicago Cooperation Grant, an IRN CNRS Predictability, Adaptability Evolution network collaboration grant, a CNRS-MIT Cooperation Grant, a q-Life Grant "The physics of repair and silencing foci?, an ERC Proof of Concept Grant "Automated evaluation and correction of generation bias in immune receptor repertoires", a DFG CRC "Predictability in evolution", an ERC International Training Network QuanTII grant, and an ERC Consolidator Grant "Statistical physics of immune-viral co-evolution”.

Reviewing editors

Yousef Abu-Amer

Washington University School of Medicine, United States

Expertise
Cell Biology
Immunology and Inflammation
Medicine

Research focus
osteolysis
osteoclast
osteoarthritis
osteoimmunology
inflammatory arthritis
RANKL
Iannis E Adamopoulos

Harvard Medical School, United States

Expertise
Immunology and Inflammation
Medicine

Research focus
osteoclasts
arthritis
psoriatic arthritis
interleukin 23
interleukin 17
RANKL
Fernán Agüero

Universidad Nacional de San Martín, Argentina

Expertise
Biochemistry and Chemical Biology
Chromosomes and Gene Expression
Computational and Systems Biology
Evolutionary Biology
Genetics and Genomics
Immunology and Inflammation
Microbiology and Infectious Disease

Research focus
genomics
drug discovery
diagnostics
infectious diseases
microbial eukaryotes
bioinformatics
Robert Baiocchi

The Ohio State University, United States

Expertise
Medicine
Cancer Biology
Immunology and Inflammation

Research focus
Epstein Barr Virus
lymphoma
cancer therapeutics
cancer vaccines
cancer immunology
cancer immunotherapy
cancer epigenetics
Muthuswamy Balasubramanyam

ICMR Emeritus Scientist, Madras Diabetes Research Foundation, India

Expertise
Medicine
Biochemistry and Chemical Biology
Cancer Biology
Cell Biology
Developmental Biology
Epidemiology and Global Health
Genetics and Genomics
Immunology and Inflammation
Neuroscience
Stem Cells and Regenerative Medicine

Research focus
disease biology
diabetes
aging
omnics
calcium signaling
endocrine disruptors
probiotics
molecular medicine
Esteban J Beckwith

Universidad de Buenos Aires - CONICET, Argentina

Expertise
Genetics and Genomics
Immunology and Inflammation
Neuroscience

Research focus
circadian
sleep
learning
memory
innate immunity
bacterial infections
insect behaviour

Experimental organism
drosophila
Gabrielle T Belz

The Walter and Eliza Hall Institute of Medical Research, Australia

Expertise
Immunology and Inflammation

Research focus
innate immunity
immune protection
adaptive immunity
transcriptional regulation
T cell memory
innate immune cells
pathogen infection
viral infection
immune cell differentiation

Experimental organism
mouse
Bérénice A Benayoun

University of Southern California, United States

Expertise
Chromosomes and Gene Expression
Genetics and Genomics
Immunology and Inflammation

Research focus
aging
macrophages
inflammation
sex differences
menopause
sex hormones

Experimental organism
mouse
African turquoise killifish
Melanie M Brinkmann

Technische Universität Braunschweig, Germany

Expertise
Immunology and Inflammation
Microbiology and Infectious Disease

Research focus
herpesviruses
innate immunity
intracellular trafficking
Marion Brunck

Tecnológico de Monterrey, Mexico

Expertise
Immunology and Inflammation
Stem Cells and Regenerative Medicine

Research focus
immunology
neutrophils
breastmilk immunity
flow cytometry
biotechnology
synthetic biology
Sara Cherry

University of Pennsylvania, United States

Expertise
Genetics and Genomics
Immunology and Inflammation
Microbiology and Infectious Disease

Research focus
virology
microbiology
innate immunity
genetics
genomics
emerging pathogens

Experimental organism
D. melanogaster
Isaac Chiu

Harvard Medical School, United States

Expertise
Immunology and Inflammation
Microbiology and Infectious Disease
Neuroscience

Research focus
neuroimmunology
pain
microglia
infection
bacterial pathogens

Experimental organism
mouse
rat
Tatyana Chtanova

Garvan Institute of Medical Research, Australia

Expertise
Immunology and Inflammation

Research focus
innate immune system
tumor immunology
two-photon microscopy
photoconversion
neutrophils
T cells
Maximiliano A D'Angelo

Sanford Burnham Prebys Medical Discovery Institute, United States

Expertise
Cancer Biology
Cell Biology
Immunology and Inflammation

Research focus
nuclear pore complex
nuclear transport
importin
exportin
immunology
cancer
muscle
Michael Dustin

University of Oxford, United Kingdom

Expertise
Immunology and Inflammation

Research focus
fluorescence microscopy
immunological synapse
signaling
membranes
affinity
Hannelore Ehrenreich

Max Planck Institute of Experimental Medicine, Germany

Expertise
Genetics and Genomics
Immunology and Inflammation
Medicine
Neuroscience

Research focus
translational neuroscience
erythropoietin
hypoxia
neuropsychiatric phenotypes
deep phenotyping
autoantibodies

Experimental organism
human
Ana Maria Faria

Universidade Federal de Minas Gerais, Brazil

Expertise
Immunology and Inflammation

Research focus
mucosal immunology
oral tolerance
inflammatory gut diseases
food allergy
immunosenescence
regulatory T cells
probiotics
gut microbiota
Evangelos J Giamarellos-Bourboulis

Attikon University Hospital, Greece

Expertise
Immunology and Inflammation
Microbiology and Infectious Disease
Genetics and Genomics
Medicine

Research focus
sepsis
hidradenitis suppurativa
pathogenesis of infection
biomarkers
Florent Ginhoux

Agency for Science Technology and Research, Singapore

Expertise
Immunology and Inflammation
Neuroscience
Stem Cells and Regenerative Medicine

Research focus
dendritic cells
monocytes
macrophages
development
hematopoiesis

Experimental organism
human
mouse
Karina A Gomez

Instituto de Investigaciones en Ingeniería Genética y Biología Molecular (INGEBI-CONICET), Argentina

Expertise
Immunology and Inflammation
Microbiology and Infectious Disease

Research focus
immunology
parasite
infection
microbiology
Leslie Goo

Fred Hutchinson Cancer Research Center, United States

Expertise
Microbiology and Infectious Disease
Immunology and Inflammation

Research focus
virology
flaviviruses
antibodies
emerging viruses
humoral immunity
Frederik Graw

Heidelberg University, Germany

Expertise
Immunology and Inflammation
Computational and Systems Biology
Microbiology and Infectious Disease

Research focus
mathematical modelling
theoretical immunology
host-pathogen interactions
viral spread
infection dynamics

Experimental organism
mouse
viruses
Brandon Harvey

NIDA/NIH, Intramural Research Program, United States

Expertise
Cell Biology
Immunology and Inflammation
Neuroscience

Research focus
neuroinflammation
ER stress
UPR
ER calcium
KDEL receptor
manf
stroke

Experimental organism
rat
mouse
human cells
Ping-Chih Ho

Ludwig Institute for Cancer Research, Switzerland

Expertise
Cancer Biology
Immunology and Inflammation
Cell Biology

Research focus
immunometabolism
cancer immunology
tumor microenvironment
immunotherapy
adaptive immunity
macrophages
metabolic disease

Experimental organism
mouse
Xiaoyu Hu

Tsinghua University, China

Expertise
Immunology and Inflammation

Research focus
macrophages
immunometabolism
intestinal epithelium
human immunology
inflammation
Stipan Jonjic

University Rijeka, Croatia

Expertise
Immunology and Inflammation

Research focus
innate immunity
viral immunology
host responses to murine cytomegalovirus infections in mice

Experimental organism
mouse
Brian S Kim

Icahn School of Medicine at Mount Sinai, United States

Expertise
Medicine
Immunology and Inflammation
Neuroscience

Research focus
basophil
cytokine
innate lymphoid cell
itch
mast cells
neuroimmunology
sensory neuron
somatosensation
Urszula Krzych

Walter Reed Army Institute of Research, United States

Expertise
Epidemiology and Global Health
Immunology and Inflammation
Microbiology and Infectious Disease

Research focus
adoptive immunity
immune memory responses
liver resident T memory cells
Plasmodium liver stage infection
Plasmodium antigens/vaccines
design of malaria vaccines
Tomohiro Kurosaki

Osaka University, Japan

Expertise
Immunology and Inflammation

Research focus
acquired immunity
vaccine development
B cell
antibody
T cell
autoimmune diseases

Experimental organism
human
mouse
Bruno Lemaitre

Ecole Polytechnique Fédérale de Lausanne, Switzerland

Expertise
Immunology and Inflammation

Research focus
innate immunity
gut
Drosophila
pattern-recognition
entomopathogens
insect endosymbionts

Experimental organism
D. melanogaster
Hongliang Li

Wuhan University School of Medicine, China

Expertise
Biochemistry and Chemical Biology
Computational and Systems Biology
Epidemiology and Global Health
Immunology and Inflammation
Medicine

Research focus
cardiometabolic disease
metabolic disease
vascular injury
animal models
liver
innate immunity
Paul Lucassen

University of Amsterdam, Netherlands

Expertise
Cell Biology
Developmental Biology
Immunology and Inflammation
Neuroscience
Stem Cells and Regenerative Medicine

Research focus
brain plasticity
(early life) stress
neurogenesis
stem cells
hippocampus
microglia
depression
dementia
cognition
nutrition/metabolism
exercise

Experimental organism
human
mouse
rat
Yuting Ma

Suzhou Institute of Systems Medicine, China

Expertise
Cancer Biology
Immunology and Inflammation
Cell Biology

Research focus
tumor immunology
immunotherapy
tumor microenvironment
stress responses
neuroendocrine-immune crosstalk
cell death
João T Marques

Universidade Federal de Minas Gerais, Brazil

Expertise
Immunology and Inflammation
Microbiology and Infectious Disease

Research focus
antiviral immunity
RNA interference
mosquito-borne viruses
nucleic acid sensing
Margaret M McCarthy

University of Maryland School of Medicine, United States

Expertise
Developmental Biology
Immunology and Inflammation
Neuroscience

Research focus
steroids
hypothalamus
social behaviour
sex differences
neuroimmunology
neuroendocrinology

Experimental organism
rat
mouse
James M McCaw

The University of Melbourne, Australia

Expertise
Epidemiology and Global Health
Microbiology and Infectious Disease
Ecology
Immunology and Inflammation

Research focus
mathematical epidemiology
virus dynamics
infectious diseases
mathematical modelling
pandemics
influenza
malaria
COVID-19
Marcelo A Mori

State University of Campinas, Brazil

Expertise
Biochemistry and Chemical Biology
Cell Biology
Chromosomes and Gene Expression
Genetics and Genomics
Immunology and Inflammation

Research focus
aging
metabolism
obesity
adipose tissue
microRNAs
endocrinology
integrative physiology
Tomohiro Morio

Tokyo Medical and Dental University, Japan

Expertise
Immunology and Inflammation
Medicine

Research focus
primary immunodeficiency
pediatrics
cell therapy
monogenic disorder
iPS cells
Shiny Nair

Yale University, United States

Expertise
Medicine
Immunology and Inflammation
Cancer Biology

Research focus
immunology
neurodegeneration
NKT cells
mycobacterium
lysosomal storage disorder
Armita Nourmohammad

University of Washington, United States

Expertise
Computational and Systems Biology
Evolutionary Biology
Physics of Living Systems
Immunology and Inflammation

Research focus
population genetics
computational immunology
adaptive immunity
statistical physics
deep mutational scanning
information theory
statistical inference
gene expression evolution

Experimental organism
D. melanogaster
human
viruses
Jalees Rehman

University of Illinois at Chicago, United States

Expertise
Cell Biology
Genetics and Genomics
Immunology and Inflammation
Medicine
Stem Cells and Regenerative Medicine

Research focus
vascular biology
macrophage biology
inflammation
transcriptomics
single cell analysis
lung biology
cell regeneration
Natalia Rubinstein

University of Buenos Aires-CONICET, Argentina

Expertise
Cancer Biology
Immunology and Inflammation
Medicine
Stem Cells and Regenerative Medicine

Research focus
breast cancer tumor cell
molecular biology
drug resistance
tumor immunology
Sarah Russell

Peter MacCallum Cancer Centre, Australia

Expertise
Cell Biology
Developmental Biology
Immunology and Inflammation

Research focus
cell fate determination
T cells
cell polarity
synapse
asymmetric cell division
Scribble

Experimental organism
mouse
Shimon Sakaguchi

Osaka University, Japan

Expertise
Immunology and Inflammation

Research focus
B cells
immune tolerance
autoimmune disease
tumor immunity
Irene Salinas

University of New Mexico, United States

Expertise
Immunology and Inflammation
Neuroscience
Evolutionary Biology
Microbiology and Infectious Disease

Research focus
mucosal immunology
neuroimmunology
host-microbe interactions
evolutionary immunology
Alan R Saltiel

University of California, San Diego, United States

Expertise
Medicine
Immunology and Inflammation
Cell Biology

Research focus
insulin
action
protein phosphorylation
obesity
metabolism
diabetes
signaling
G proteins
Rebecca M Sappington

Wake Forest School of Medicine, United States

Expertise
Medicine
Neuroscience
Immunology and Inflammation
Developmental Biology

Research focus
retina
optic nerve
neurodegeneration
glia
neuroinflammation
regeneration
axon
cytokine/chemokine
Apurva Sarin

Institute for Stem Cell Science and Regenerative Medicine, India

Expertise
Cell Biology
Immunology and Inflammation

Research focus
apoptosis
Notch1
signal transduction
T cells

Experimental organism
mouse
Joshua T Schiffer

Fred Hutchinson Cancer Research Center, United States

Expertise
Microbiology and Infectious Disease
Epidemiology and Global Health
Immunology and Inflammation
Medicine

Research focus
mathematical modelling
herpesviruses
HIV
COVID-19
T cell immunology

Experimental organism
human
viruses
HSV
SARS-CoV-2
John W Schoggins

University of Texas Southwestern Medical Center, United States

Expertise
Microbiology and Infectious Disease
Immunology and Inflammation

Research focus
innate immunity
virology
antiviral
interferon

Experimental organism
human
mouse
bats
Jiwon Shim

Hanyang University, South Korea

Expertise
Cell Biology
Developmental Biology
Genetics and Genomics
Immunology and Inflammation

Research focus
hematopoiesis
innate immunity
hemocyte
development
signaling
inter-organ communication

Experimental organism
D. melanogaster
Kellie N Smith

Johns Hopkins University School of Medicine, United States

Expertise
Medicine
Immunology and Inflammation

Research focus
cancer immunology
T cells
immunogenomics
T cell receptors
neoantigens
lung cancer
Jungsan Sohn

Johns Hopkins University School of Medicine, United States

Expertise
Biochemistry and Chemical Biology
Structural Biology and Molecular Biophysics
Immunology and Inflammation
Microbiology and Infectious Disease

Research focus
innate immunity
inflammasomes
X-ray crystallography
cryo-EM
biochemistry
enzyme kinetics
Pramod K Srivastava

UConn Health, United States

Expertise
Medicine
Immunology and Inflammation

Research focus
cancer immunology
tumor antigens
neoantigens
cancer vaccines
immunotherapy
antigen presentation
neoepitopes
cross-presentation

Experimental organism
mouse
human
Christina L Stallings

Washington University School of Medicine, United States

Expertise
Microbiology and Infectious Disease
Immunology and Inflammation
Chromosomes and Gene Expression

Research focus
bacterial pathogenesis
mycobacterium tuberculosis
bacterial transcription
innate immune responses
host-pathogen interactions
Beth Stevens

Boston Children's Hospital, United States

Expertise
Neuroscience
Immunology and Inflammation

Research focus
microglia
neuron-glia interactions
synapse loss
neuro-immune interactions
activity-dependent circuit refinement

Experimental organism
mouse
Kiyoshi Takeda

Osaka University, Japan

Expertise
Immunology and Inflammation
Medicine

Research focus
mucosal immunology
inflammatory bowel disease
intestinal immunity
intestinal environmental factors
intestinal epithelial cells
Mauro M Teixeira

Universidade Federal de Minas Gerais, Brazil

Expertise
Medicine
Immunology and Inflammation
Microbiology and Infectious Disease

Research focus
inflammation
mediators of inflammation
pharmacology
anti-viral compounds
arboviral infections
clinical trials
Dario Riccardo Valenzano

Max Planck Institute for Biology of Ageing, Germany

Expertise
Evolutionary Biology
Genetics and Genomics
Immunology and Inflammation
Microbiology and Infectious Disease

Research focus
biology of aging
microbiome
killifish
neutral evolution
mutation load
comparative genomics
immunosenescence
Frank van de Veerdonk

Radboud University Medical Center, Netherlands

Expertise
Immunology and Inflammation
Microbiology and Infectious Disease
Medicine

Research focus
medical mycology
clinical immunology
Russell E Vance

University of California, Berkeley, United States

Expertise
Immunology and Inflammation
Microbiology and Infectious Disease

Research focus
innate immunity
bacterial pathogenesis
interferon
inflammasomes
pathogen-sensing

Experimental organism
mouse
L. pneumophila
M. tuberculosis
David Wallach

The Weizmann Institute of Science, Israel

Expertise
Cell Biology
Immunology and Inflammation

Research focus
apoptosis
caspase
cell death
necroptosis
NF-kB
TNF
TNF-family
Chyung-Ru Wang

Northwestern University, United States

Expertise
Immunology and Inflammation

Research focus
MHC Ib-restricted T cells
CD1
antigen presentation
lipid antigens
mycobacterium tuberculosis
immunity against bacterial pathogens

Experimental organism
mouse
Linghua Wang

The University of Texas MD Anderson Cancer Center, United States

Expertise
Cancer Biology
Computational and Systems Biology
Genetics and Genomics
Immunology and Inflammation
Medicine

Research focus
computational biology
cancer immunogenomics
cancer genomics
Jia Wei

Clinical Cancer Institute of Nanjing University, China

Expertise
Cancer Biology
Immunology and Inflammation

Research focus
cancer immunotherapy
immune evasion
tumor immune microenvironment
tumor neoantigen
adoptive cell therapy
tumor-associated macrophages
gastric cancer
immune checkpoints
Simon Yona

The Hebrew University of Jerusalem, Israel

Expertise
Immunology and Inflammation

Research focus
monocytes
macrophages
dendritic cells
inflammation

Experimental organism
mouse
human
Dario S Zamboni

Universidade de Sao Paulo, Brazil

Expertise
Cell Biology
Immunology and Inflammation
Microbiology and Infectious Disease

Research focus
parasitology
innate immunity
inflammation
inflammasome
intracellular receptors
mouse models of infection
pathogen-host cell interaction
Juan Carlos Zúñiga-Pflücker

University of Toronto, Sunnybrook Research Institute, Canada

Expertise
Immunology and Inflammation
Stem Cells and Regenerative Medicine

Research focus
developmental immunology
thymus
T cell development
notch signaling
lymphopoiesis
preTCR signaling
gamma/delta T cell differentiation

Experimental organism
human
mouse